With CEO Tim Cook pumping unprecedented cash into R&D, Jay Walker, Patent Properties chairman, discusses Apple's upcoming product line and how patents create jobs and drive stock prices.» Read More
Former Enron Chief Financial Officer Andy Fastow has been transferred to a Houston halfway house as he prepares to be released from prison later this year.
Righthaven, a Nevada company, finds newspaper material that has been republished on the Web and obtains the copyrights. Then it sues, the New York Times reports.
A federal court jury has rejected Mattel Inc.'s copyright infringement claims involving MGA Entertainment's popular line of Bratz dolls and awarded MGA $88.4 million for misappropriation of its trade secrets by the Barbie-maker.
The drug industry stands to lose billions of dollars a year, as patents to their key drugs expire, with David Brennan, Astrazeneca CEO.
Shares of Eastman Kodak surged 20 percent in late trading on Friday after the International Trade Commission said that it would review the camera maker's loss in a patent battle with Research in Motion and Apple.
The Senate on Monday will begin debating a bill that critics say will undermine American strength abroad, plunder the United States economy and exceed the government’s constitutional authority. The subject: patent reform. The New York Times reports.
The SEC has chosen a former Altria and AOL executive to head its new Whistleblower Office, the commission said Friday. Sean McKessy will wield the new power given to the SEC under the Dodd-Frank law passed last year.
Whistleblowers who expose fraud, corruption and other kinds of wrongdoing can be deeply religious people, whose faith gives them an identity outside their corporate life.
With new whistleblower rules coming to Wall Street, the industry's lobbyists have mounted a furious behind-the-scenes effort to constrain the reach of the new protections.
Two men, including a Wall Street veteran and a Minnesota trader who went undercover, explain how they worked with the IRS and FBI to expose tax fraud.
This is the story of the most successful—and least known—whistleblower operation of all time. Four men who have made a vast fortune blowing the whistle on the drug industry, forcing Big Pharma to pay the federal government over a billion dollars in settlements.
Bradley Birkenfeld once lived the high life as secret Swiss banker at UBS in Geneva. Then he delivered some of the world’s best-kept secrets to the US government, expecting a great reward. And now he sits in federal prison in Pennsylvania.
Cheryl Eckard became the largest individual whistleblower award recipient ever, hauling in a $96 million bounty as her reward for providing information to the government about manufacturing problems at GlaxoSmithKline.
Have you ever been tempted to blow the whistle on something suspicious you've witnesses in the workplace? Take our poll and share your opinion.
Forget what you think you know about lone whistleblowers taking on giant corporations all by themselves. These days, there's a cottage industry to support—and profit from—whistleblowing.
When President Barack Obama signed the Dodd-Frank Wall Street reform act into law last summer, very few in the financial industry knew that the bill included a massive change in the way whistleblowing law works in this country.
That promise of cash is providing a new incentive for employees to reveal wrongdoing in their companies. What would you do?
Wall Street is suddenly paying attention to the culture of whistleblowing, because the new Dodd-Frank financial reform law, for the first time, extends whistleblower provisions to Wall Street, meaning employees who expose fraud and wrongdoing stand to collect between 10 and 30 percent of the amount recovered by the government.
Taking a look at the biggest fraud cases of all time, and you're left with just one question: What's wrong with the pharmaceutical industry?